PREGMIT Tablet

Use in the control of nausea and vomiting associated with pregnancy.

Dosage and Directions for use

2 tables at bedtime, 1 additional tablet before rising and another in mid-afternoon in severe cases.

During acute attacks of asthma. It should not be administered to epileptics as it may precipitate fits.

Doxylamine succinate may cause drowsiness, lassitude, dizziness and inco-ordination. Other side-effects include gastrointestinal disturbances such as nausea, vomiting, diarrhoea or constipation, anorexia or increased appetite, and epigastric pain, blurred vision, difficulty in micturition, dysuria, dryness of the mouth, and tightness of the chest, hypotension, muscular weakness, tinnitus, euphoria, and occasionally headache.

See "special precautions".

The use of this medicine leads to drowsiness which is aggravated by the simultaneous intake of alcohol and other CNS depressants. PREGMIT should not be administered concurrently with monoamine oxidase inhibitors.

Antihistaminic, Anti-emetics and Antivertigo preparations.

PREGMIT tablets are enteric coated tablets consisting of a combination of Doxylamine succinate which imparts antihistaminic combination of Doxylamine succinate which imparts antihistaminic actions to the preparation and also gives it a sedative effect, and Pyridoxine hydrochloride and folic acid have been added to enhance the anti-emetic effects and as a dietary supplement.